New Data From iRhythm Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable Arrhythmias

SAN FRANCISCO, May 22, 2023 -- Rhythm Technologies, Inc. , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today the... | May 22, 2023

Related Keywords

United States ,Matthewm Zipse ,Mario Delmar ,Matthew Needleman ,Spencerz Rosero ,Francise Marchlinski ,Mike Hsu ,Juliah Indik ,Christopher Madias ,Andrew Krumerman ,Johns Hopkins ,Derickr Peterson ,Morgan Mathis ,Alberty Sun ,Cynthiaa James ,Bronislava Polonsky ,David Oakes ,Alext Sandhu ,Alan Wilk ,Paula Heidenreich ,Kevinj Ferrick ,Lori Crosson ,Martins Maron ,Hugh Calkins ,Mintu Turakhia ,Krishna Pundi ,Stephanie Zhadkevich ,Markc Haigney ,Mintup Turakhia ,Jayj Chudow ,Scott Mcnitt ,Ardit Kacorri ,Gaurav Das ,Barryj Maron ,Jamesp Daubert ,Luisa Mestroni ,Nasdaq ,Veterans Health Administration ,Heart Rhythm Society ,Globenewswire Inc ,University Of Rochester ,Va Health Care System ,Rhythm Technologies Inc ,Heart Rhythm ,Enhances Identification ,Premature Ventricular Complexes ,Assessing Burden Density ,Large National Cohort Population ,Better Define Optimal ,Practice Variation After Ambulatory ,Non Sustained Ventricular Tachycardia ,Health Administration ,Care System ,Randomized Placebo Controlled Trial ,Patients With Arrhythmogenic Right Ventricular ,Higher Risk Patients With Hypertrophic ,Ventricular Complexes ,Variation After Ambulatory ,Placebo Controlled Trial ,Rhythm Technologies ,Relations Contact ,Rhythm Media Contact ,Irhythm Technologies ,Nc Stock Exchange ,News ,Information ,Press Release ,Han ,Bay ,023 ,Rhythm ,Reading ,Digital ,Health ,Mare ,Company ,Ocused ,N ,Reating ,Rusted ,Solutions ,Hat ,End ,Prevent ,Nnounced ,Oday Irtc Us4500561067 ,